title: Are gains of chromosomal regions 7q and 11p important abnormalities in neuroblastoma?
abstract: Neuroblastoma exhibiting deletion of a segment of the long arm of chromosome 11 represents a genetic subtype of tumor that is distinct from those exhibiting MYCN amplification or 1p deletion. The 11q- genetic subtype is further characterized by gain of 17q and loss of distal 3p material. Gain of 11p material has also been reported in neuroblastoma with 11q loss, but at a considerably lower frequency than gain of 17q or loss of the distal 3p region. Our results, however, indicate that gain of 11p may occur more frequently in 11q- neuroblastoma than what was previously realized. Comparative genomic hybridization analyses of neuroblastoma tissue from eleven patients indicated that six of 11 tumors (55%) with loss of 11q also possessed gain of 11p. The shortest region of 11p gain was 11p11.2-->p14. G-banding and fluorescence in situ hybridization analysis performed on tumor cells from primary and metastatic sites from one patient allowed us to infer that gain of 11p arose secondarily to the abnormality that led to the loss of 11q material. Gain of an entire chromosome 7 was detected in 17 of 43 (40%) tumors, whereas gain of 7q was detected in 5 of 43 (12%) tumors. Unlike gain of 11p, gain of an entire chromosome 7 appears to be prevalent in all tumor stages and is not limited to the 11q- tumor subtype. Gain of 7q, however, is more prevalent in higher stage tumors. G-band cytogenetic analysis indicated that an unbalanced t(3;7) was responsible for the gain of 7q and loss of 3p material in one case. We discuss the possibility that gain of 7/7q, and 11p material may contribute to either tumorigenesis or progression.
authors.affiliation: National Centre for Medical Genetics, Our Lady's Hospital for Sick Children, Crumlin, Dublin 12, Ireland. ray.stallings@olhsc.ie
authors.forename: R L
authors.initials: RL
authors.lastname: Stallings
authors.forename: J
authors.initials: J
authors.lastname: Howard
authors.forename: A
authors.initials: A
authors.lastname: Dunlop
authors.forename: M
authors.initials: M
authors.lastname: Mullarkey
authors.forename: M
authors.initials: M
authors.lastname: McDermott
authors.forename: F
authors.initials: F
authors.lastname: Breatnach
authors.forename: A
authors.initials: A
authors.lastname: O'Meara
mesh_terms: D000008:Abdominal Neoplasms / Q000235:genetics / Q000473:pathology; D002471:Cell Transformation, Neoplastic / Q000235:genetics; D002869:Chromosome Aberrations; D002871:Chromosome Banding; D002872:Chromosome Deletion; D020223:Chromosome Painting; D002880:Chromosomes, Human, Pair 11 / Q000235:genetics / Q000648:ultrastructure*; D002897:Chromosomes, Human, Pair 7 / Q000235:genetics / Q000648:ultrastructure*; D005784:Gene Amplification; D006258:Head and Neck Neoplasms / Q000235:genetics / Q000473:pathology; D006801:Humans; D008207:Lymphatic Metastasis; D009447:Neuroblastoma / Q000235:genetics* / Q000473:pathology; D009693:Nucleic Acid Hybridization; D017384:Sequence Deletion; D013899:Thoracic Neoplasms / Q000235:genetics / Q000473:pathology